Publications
5600 Results
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr TPS3154); American Society of Clinical Oncology 2020 Annual Meeting, poster
- Year
- 2020
- Study Number(s)
- CTSU/A151804
ALLIANCE A151804: Establishment of a National Biorepository to Advance Studies of Immune-related Adverse Events
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 8038); American Society of Clinical Oncology 2020 Annual Meeting, poster
- Year
- 2020
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016, S0801
Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 11562); American Society of Clinical Oncology 2020 Annual Meeting, poster
- Year
- 2020
A Randomized Phase II Study of MLN0128 (M) vs. Pazopanib (P) in Pts with Advanced Sarcoma (Alliance A091304)
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr e16076); American Society of Clinical Oncology 2020 Annual Meeting, publication only
- Year
- 2020
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405, N9741
Rural and urban disparities based on zip code of residence: Analyses of 834 and 2159 patients in N9741 and CALGB 80405 trials respectively.
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 4086); American Society of Clinical Oncology 2020 Annual Meeting, poster
- Year
- 2020
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Predictive and prognostic value of HER2 gene expression and HER2 amplification in patients with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance)
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 10059); American Society of Clinical Oncology 2020 Annual Meeting, poster
- Year
- 2020
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1320
Improved clinical outcomes in patients with BRAFV600 mutant melanoma and undetectable circulating tumor DNA treated with dabrafenib and trametinib
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 12019); American Society of Clinical Oncology 2020 Annual Meeting, poster discussion
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1105
Predictive Model of Aromatase Inhibitor Non-Adherence Using Patient-Reported Outcomes in Women with Breast Cancer (SWOG S1105)
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 5028); American Society of Clinical Oncology 2020 Annual Meeting, poster
- Year
- 2020
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1314
Association of Molecular Expression Based Subtypes with Pathologic Response in a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer (SWOG S1314; NCT02177695)
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr e19068); American Society of Clinical Oncology 2020 Annual Meeting, publication only
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery and Cancer Survivorship
- Study Number(s)
- S0316
Beyond Patient-Level Barriers: Evaluation of Rural Residency and Area-Level Deprivation and Clinical Trial Participation
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 6500); American Society of Clinical Oncology 2020 Annual Meeting, LBA, oral
- Year
- 2020